Investigation on the cause of recurrent tuberculosis in a rural area in China using whole-genome sequencing: A retrospective cohort study

肺结核 医学 回顾性队列研究 抗药性 内科学 耐药结核 广泛耐药结核 队列 单核苷酸多态性 队列研究 耐多药结核病 人口 结核分枝杆菌 儿科 基因型 基因 遗传学 病理 生物 环境卫生
作者
Meng Li,Yong Qiu,Mingcheng Guo,Shu Zhang,Gengsheng Wang,Ya Wang,Lan Xia,Qian Gao
出处
期刊:Tuberculosis [Elsevier BV]
卷期号:133: 102174-102174 被引量:11
标识
DOI:10.1016/j.tube.2022.102174
摘要

Recurrent tuberculosis (TB) in China has been studied in urban areas but not in rural settings. We conducted a retrospective cohort study on all successfully treated bacteriologically confirmed TB patients between 2009 and 2020 in Wusheng County, Sichuan Province using whole-genome sequencing (WGS). Isolates differing by ≤ 12 single nucleotide polymorphisms (SNPs) were considered relapse, otherwise were considered exogenous reinfection, and molecular drug susceptibility results were also compared. In total, 4.9% (75/1532) of successfully treated cases had subsequent bouts of TB, with 4 patients having two subsequent bouts, yielding a total of 79 events and a rate of 8.56 (95% CI 6.86-10.67) cases per 1000 person years, 8.9 times higher than in the general population. Most recurrences (74.4%, 58/79) occurred within three years. The risk for recurrent TB was increased for men and patients with drug-resistant isolates. Among the 44 recurrent events with genotyped paired isolates, 39 were classified as relapse and 5 as exogenous reinfection. Ten (25%, 10/40) recurrent patients acquired new resistance during treatment. Recurrent TB in rural Wusheng was mostly relapse and associated with drug resistance, suggesting the need to improve patient management, resistance testing and patient follow-up for at least 3 years after completing treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
中将发布了新的文献求助10
刚刚
明亮的嚣完成签到,获得积分10
刚刚
wx1067035397发布了新的文献求助10
刚刚
斯文的天德完成签到,获得积分20
刚刚
m同学完成签到,获得积分10
刚刚
1秒前
科研通AI6.1应助狂野石头采纳,获得50
1秒前
1秒前
1秒前
12333发布了新的文献求助10
1秒前
xyh发布了新的文献求助10
1秒前
玉锋堪截云完成签到,获得积分10
2秒前
2秒前
3秒前
凌云客完成签到,获得积分20
3秒前
kt关闭了kt文献求助
3秒前
BUG完成签到,获得积分10
3秒前
淡定初蓝完成签到,获得积分10
3秒前
可爱的函函应助颜十三采纳,获得10
4秒前
小章完成签到,获得积分10
4秒前
Ava应助玖依采纳,获得10
4秒前
传奇3应助luhui采纳,获得10
5秒前
陈陈完成签到,获得积分10
5秒前
sparks发布了新的文献求助10
6秒前
7秒前
Hello应助如忆婧年采纳,获得10
7秒前
爰爰完成签到,获得积分10
7秒前
8秒前
璐璐baby发布了新的文献求助10
8秒前
Aqua发布了新的文献求助30
8秒前
8秒前
8秒前
哈哈哈哈完成签到 ,获得积分10
8秒前
Anker发布了新的文献求助10
9秒前
彭于晏应助明亮的嚣采纳,获得10
10秒前
bluesky完成签到,获得积分10
10秒前
10秒前
11秒前
JamesPei应助xyh采纳,获得10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
Standard: In-Space Storable Fluid Transfer for Prepared Spacecraft (AIAA S-157-2024) 1000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5949030
求助须知:如何正确求助?哪些是违规求助? 7120212
关于积分的说明 15914589
捐赠科研通 5082170
什么是DOI,文献DOI怎么找? 2732391
邀请新用户注册赠送积分活动 1692845
关于科研通互助平台的介绍 1615544